A detailed history of Corton Capital Inc. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 57,849 shares of TRDA stock, worth $1.02 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
57,849
Previous 54,973 5.23%
Holding current value
$1.02 Million
Previous $783,000 18.14%
% of portfolio
0.47%
Previous 0.43%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.65 - $17.86 $39,257 - $51,365
2,876 Added 5.23%
57,849 $925,000
Q2 2024

Aug 14, 2024

BUY
$11.85 - $16.45 $163,897 - $227,519
13,831 Added 33.62%
54,973 $783,000
Q1 2024

May 15, 2024

BUY
$11.58 - $17.0 $145,514 - $213,622
12,566 Added 43.97%
41,142 $582,000
Q4 2023

Feb 14, 2024

BUY
$11.36 - $16.99 $205,513 - $307,366
18,091 Added 172.54%
28,576 $431,000
Q3 2023

Nov 14, 2023

SELL
$13.61 - $18.01 $103,191 - $136,551
-7,582 Reduced 41.97%
10,485 $165,000
Q2 2023

Aug 14, 2023

BUY
$11.02 - $18.01 $199,098 - $325,386
18,067 New
18,067 $273,000

Others Institutions Holding TRDA

About Entrada Therapeutics, Inc.


  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $551M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.